Bottom line
GTHRX vs IYH: the short answer
GTHRX (INVESCO Health Care Fund) and IYH (iShares U.S. Healthcare ETF) are both mutual funds.
IYH is cheaper at 0.37% vs 1.32% — a difference of $95 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +3.5% for GTHRX.
Updated Nov 19, 2026
GTHRX vs IYH side by side
| GTHRX | IYH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Invesco | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.32% | 0.37% |
| Annual cost per $10k | $132 | $37 |
| 10-yr cost on $10k (prospectus) | $1,590 | $468 |
| Max front load | 0% | None |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +15.2% | +13.1% |
| 5-yr return (annualized) | +3.5% | +7.0% |
| 10-yr return (annualized) | +6.1% | +9.4% |
| Best quarter | +19.6% | +15.3% |
| Worst quarter | −16.5% | −12.7% |
| Net assets (fund) | $1.2B | $3.6B |
| Number of holdings | 82 | 103 |
| Portfolio turnover | 59% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GTHRX | IYH | Difference |
|---|---|---|---|
| 2024 | +4.0% | +3.1% | +0.9% |
| 2023 | +3.1% | +2.1% | +1.0% |
| 2022 | −13.5% | −4.4% | −9.2% |
| 2021 | +12.2% | +23.4% | −11.2% |
| 2020 | +14.5% | +15.5% | −1.0% |
| 2019 | +32.0% | +20.8% | +11.2% |
| 2018 | +0.5% | +5.9% | −5.4% |
| 2017 | +15.5% | +22.3% | −6.9% |
| 2016 | −11.7% | −2.8% | −8.9% |
| 2015 | +3.0% | +6.1% | −3.2% |
Source: Fund prospectus bar charts
Holdings overlap
9 of GTHRX's top 25 holdings also appear in IYH's top 25.
| Holding | GTHRX | IYH |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 15.11% |
| Johnson & Johnson | 6.76% | 10.17% |
| UnitedHealth Group Inc. | 6.17% | 6.16% |
| Merck & Co., Inc. | 4.59% | 5.31% |
| AbbVie Inc. | 4.03% | 7.32% |
| Gilead Sciences, Inc. | 3.63% | 2.66% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.00% |
| Edwards Lifesciences Corp. | 1.56% | 0.81% |
| Thermo Fisher Scientific Inc. | 1.55% | 3.52% |
Source: SEC Form N-PORT
GTHRX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between GTHRX and IYH?
Which is cheaper, GTHRX or IYH?
Should I own both GTHRX and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.